Bone morphogenetic protein receptor-II mutation Arg491Trp causes malignant phenotype of familial primary pulmonary

Jing Zhicheng1, Lu Lihe, Han Zhiyan

  • 1Department of Cardiololgy, Fu Wai Heart Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, No.167 Beilishilu, Beijing 100037, China.

Insights

A novel BMPR-II gene mutation, Arg491Trp, was identified in a family with primary pulmonary hypertension. This finding advances understanding of familial pulmonary hypertension genetics and potential therapeutic targets.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Familial primary pulmonary hypertension (FPPH) is a rare, severe condition.
  • Genetic factors play a significant role in FPPH pathogenesis.
  • The bone morphogenetic protein receptor-II (BMPR-II) gene is a key candidate in FPPH.

Purpose of the Study:

  • To identify genetic mutations associated with FPPH in a multi-generational family.
  • To investigate the role of the BMPR-II gene in the identified FPPH cases.
  • To analyze the segregation and prevalence of identified mutations.

Main Methods:

  • Pedigree analysis of a four-generation family with 14 living members.
  • DNA sequencing to screen for mutations in the BMPR-II gene.
  • Exclusion analysis in sporadic primary pulmonary hypertension patients and normal individuals.

Main Results:

  • A C-to-T transition in exon 11 of the BMPR-II gene was identified, causing an Arg491Trp mutation.
  • This Arg491Trp mutation segregated with FPPH within the family.
  • No BMPR-II mutations were found in sporadic primary pulmonary hypertension cases or 240 normal chromosomes.
  • The mutation is located in the kinase domain, potentially affecting BMPR-II function.

Conclusions:

  • The identified Arg491Trp mutation in the BMPR-II gene is strongly associated with familial primary pulmonary hypertension.
  • This discovery provides a specific genetic marker for FPPH in this family.
  • Further research is needed to understand the impact of modifiers on clinical phenotype variability.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...